查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966203

全球增生性瘢痕和瘢痕疙瘩治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Hypertrophic And Keloid Scar Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2025 年，增生性瘢痕和瘢痕疙瘩治療的市場規模將達到 92.4 億美元，到 2034 年將達到 256.5 億美元，2026 年至 2034 年的複合年成長率為 12.02%。

由於人們對美容和皮膚科治療的意識不斷提高，全球增生性瘢痕和瘢痕疙瘩治療市場正在擴張。外科手術、燒燙傷和創傷的發生率不斷上升，也推動了對疤痕管理解決方案的需求成長。微創手術和雷射治療技術的進步正在改善治療效果。消費者對美觀的追求也進一步推動了市場成長。

關鍵成長要素包括皮質類固醇注射、冷凍療法、矽膠貼片和雷射治療等技術進步。在全球範圍內，皮膚科診所和美容中心的數量不斷增加，提高了人們獲得專業醫療服務的便利性。社群媒體的影響和可支配收入的成長也促使消費者尋求美容治療。此外，再生醫學的持續研究正在拓展治療選擇。

展望未來，由於非侵入性治療和聯合療法的持續創新，預計市場將穩步成長。隨著醫療基礎設施的擴展，新興市場有望展現出巨大的成長潛力。對皮膚病學研發投入的增加可望加速產品開發。在患者對有效且價格合理的疤痕治療需求不斷成長的推動下，市場預計將持續發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球增生性瘢痕與瘢痕疙瘩治療市場：依瘢痕類型分類

  • 市場分析、洞察與預測
  • 肥大的
  • 瘢痕疙瘩

第5章 全球增生性瘢痕和瘢痕疙瘩治療市場：依產品類型分類

  • 市場分析、洞察與預測
  • 外部雷射產品
  • 產品
  • 注射藥物
  • 其他

第6章 全球增生性疤痕和瘢痕疙瘩治療市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 其他

第7章 全球增生性疤痕和瘢痕疙瘩治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和分銷通路合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Alliance Pharma PLC
    • MoLnlycke Health Care AB
    • Smith & Nephew
    • Newmedical Technology Inc
    • RejAfAVaskin
    • Sonoma PharmaceuticalsInc
    • Suneva Medical
    • HRA Pharma
    • Lumenis
    • Perrigo Company Plc
簡介目錄
Product Code: VMR11210559

The Hypertrophic And Keloid Scar Treatment Market size is expected to reach USD 25.65 Billion in 2034 from USD 9.24 Billion (2025) growing at a CAGR of 12.02% during 2026-2034.

The Global Hypertrophic and Keloid Scar Treatment Market has expanded due to increasing awareness of cosmetic and dermatological treatments. Rising incidence of surgical procedures, burns, and traumatic injuries has contributed to greater demand for scar management solutions. Advances in minimally invasive procedures and laser therapies have improved treatment outcomes. Growing consumer focus on aesthetic appearance further supports market growth.

Key growth drivers include technological advancements in corticosteroid injections, cryotherapy, silicone gel sheets, and laser-based treatments. The increasing availability of dermatology clinics and aesthetic centers worldwide has enhanced access to specialized care. Social media influence and rising disposable incomes also encourage consumers to seek cosmetic treatments. Additionally, ongoing research into regenerative medicine is expanding therapeutic options.

Looking ahead, the market is expected to grow steadily with continuous innovation in non-invasive and combination therapies. Emerging markets offer strong growth potential due to expanding healthcare infrastructure. Increasing investment in dermatology research will enhance product development. As patient demand for effective and affordable scar treatments rises, the market will continue to evolve.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Scar Type

  • Hypertrophic
  • Keloid

By Product Type

  • Topical Laser Products
  • Products
  • Injectables
  • Other

By End User

  • Hospitals
  • Clinics
  • Others

COMPANIES PROFILED

  • Alliance Pharma PLC, Mlnlycke Health Care AB, Smith Nephew, Newmedical Technology Inc, Rejvaskin, Sonoma Pharmaceuticals, Inc, Suneva Medical, HRA Pharma, Lumenis, Perrigo Company plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY SCAR TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Scar Type
  • 4.2. Hypertrophic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Keloid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product Type
  • 5.2. Topical Laser Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Injectables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Scar Type
    • 7.2.2 By Product Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Scar Type
    • 7.3.2 By Product Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Scar Type
    • 7.4.2 By Product Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Scar Type
    • 7.5.2 By Product Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Scar Type
    • 7.6.2 By Product Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HYPERTROPHIC AND KELOID SCAR TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Alliance Pharma PLC
    • 9.2.2 MA¶Lnlycke Health Care AB
    • 9.2.3 Smith & Nephew
    • 9.2.4 Newmedical Technology Inc
    • 9.2.5 RejAfAVaskin
    • 9.2.6 Sonoma PharmaceuticalsInc
    • 9.2.7 Suneva Medical
    • 9.2.8 HRA Pharma
    • 9.2.9 Lumenis
    • 9.2.10 Perrigo Company Plc